InsidersTradesSigma
Natco Pharma Limited: directors' dealings · India · SEBI (PIT + SAST)
SEBI:natco-pharma-limitedIN·SEBI (PIT + SAST)Mcap 142.9Bn€
Explore the full insider trade history of Natco Pharma Limited, a listed issuer based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €142.9bn. The latest transaction was reported on 11 March 2026 — Sale. Among the most active insiders: SATYA VANI NANNAPANENI. All data is openly available.
76
Insider Decl.
0
Thresholds
€572,962
28 ops.
Buy Volume
€7m
48 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
1165.60 €
Income statement
Revenue44.12 Bn€
Gross profit35.46 Bn€80% margin
Net income18.85 Bn€42.7% margin
Balance sheet & cash
Market cap142.88 Bn€
Total debt2.79 Bn€
Free Cash Flow11.85 Bn€
Last declaration on 11 March 2026
Declarations76 total
Executives●Sale0SEBI
€420,31945,000 shares@ €9.3404
Equity Shares
SEBI:e6cac393a77a52cae1534ede84b97186a637e9b0·
Executives●Sale0SEBI
€664,26070,000 shares@ €9.4894
Equity Shares
SEBI:274dc5941df2918e536d89fc2bfcd269e582cd13·
Executives●Sale0SEBI
€771,091100,000 shares@ €7.7109
Equity Shares
SEBI:b08d1b8e9605bade4516a11dd1e0d4ec399a5bbf·
Executives●Sale0SEBI
€188,87823,000 shares@ €8.2121
Equity Shares
SEBI:16948d1eb5e3ec3fdb2ea5f44509de7f3065cee1·
Executives●Sale0SEBI
€140,12917,149 shares@ €8.1713
Equity Shares
SEBI:9ffdd87051e298ebbb63db64f86914adba0a9643·
Executives●Purchase0SEBI
€883100 shares@ €8.8291
Equity Shares
SEBI:1b9deaf7970e7608c7be0f27c798bb058ada382e·
Ideal exit: 6 Mar 2026 (T+270)
Executives●Purchase0SEBI
0286,910 shares
Equity Shares
SEBI:086f24f983a07e21aa405ad1dc4c722a752cf11e·
Ideal exit: 21 Dec 2025 (T+270)
Executives●Sale0SEBI
050,000 shares
Equity Shares
SEBI:b899a66b81d317207d8c94e953ffd5c1155da4be·
Executives●Sale0SEBI
050,000 shares
Equity Shares
SEBI:7673e337270d9bf663439c6cbea7f607855d437d·
Executives●Purchase0SEBI
0420,000 shares
Equity Shares
SEBI:a037f2c7f2c299fd3bf94f3db34b48bc76e937e5·
Ideal exit: 25 Nov 2025 (T+270)
Executives●Purchase0SEBI
040,000 shares
Equity Shares
SEBI:8a74d3cf1b8972d8512eed280c6425f499a76eec·
Ideal exit: 25 Nov 2025 (T+270)
Executives●Sale0SEBI
€31,2392,000 shares@ €15.6194
Equity Shares
SEBI:37d071edfff92776d7694139635f4d6cd66f3b77·
Executives●Sale0SEBI
€38,9272,500 shares@ €15.5707
Equity Shares
SEBI:12bd856ff31282f7a3e05f9cc16c6a1f515831fa·
Executives●Sale0SEBI
€83,4195,000 shares@ €16.6837
Equity Shares
SEBI:e1fc2c83247a42a1e79cb4fc61e3efcf5cfb7ce7·
Executives●Sale0SEBI
€15,1591,000 shares@ €15.1587
Equity Shares
SEBI:5f464b82c5f8f5884e3244b19bf3b79bcc9bdcb4·
Executives●Sale0SEBI
€13,887900 shares@ €15.4301
Equity Shares
SEBI:9169abafd8d2a94d5ee68dac24c2f1025197f8fb·
Executives●Sale0SEBI
€26,2121,500 shares@ €17.4746
Equity Shares
SEBI:6e6d3a2ce1fd7f820cf600cc6fabf0a0d470b4c1·
Executives●Sale0SEBI
€21,8331,310 shares@ €16.6668
Equity Shares
SEBI:f5ec543a023213dd09a44dc11fdeec7cb286e7b2·
Executives●Sale0SEBI
€33,0242,000 shares@ €16.5122
Equity Shares
SEBI:97882e18b322c5328d540b673293a34d88a441df·
Executives●Sale0SEBI
€325,44920,000 shares@ €16.2725
Equity Shares
SEBI:6348dadc81ff1c6b364891e4239cce2082a23720·
Executives●Sale0SEBI
€10,022600 shares@ €16.7039
Equity Shares
SEBI:024d259271577b68ba0f8f86113165e069232ec7·
Executives●Sale0SEBI
€155,48510,000 shares@ €15.5485
Equity Shares
SEBI:ba02d467b978035126372be0ac69b69c4dd2f046·
Executives●Sale0SEBI
€1m75,000 shares@ €15.6626
Equity Shares
SEBI:cf4f56f046ddfef1f4098aff5919a0b6d0a94cdb·
Executives●Sale0SEBI
€181,32211,563 shares@ €15.6812
Equity Shares
SEBI:50ee1589d01fe3ab88b76bdb3d84a4ed4fa23b05·
25 of 76 declarations